Cyclic Epitalon Administration: 25% Lifespan Extension in Aged Mice
10 mg nightly for 20 days, cycled 3x/year — the complete anti-aging protocol backed by a 52-week murine study
Key Findings
- 1Cyclic Epitalon (10 mg nightly × 20 days, 3 cycles/year) extended median lifespan by 25% (912 → 1140 days)
- 2Frailty index reduced by 45% throughout late life
- 3Telomere length preserved by 35% at 26 weeks (T/S ratio 1.35 vs. 1.00)
- 4Mitochondrial ATP production increased by 40%
- 5Oxidative stress (ROS/MDA) decreased by 45%, inflammation (TNF-α/IL-6) reduced by 50%
- 6Cognitive function improved by 40% (Morris water maze escape latency)
What Is Epitalon?
Epitalon is a synthetic tetrapeptide (Ala-Glu-Asp-Gly) derived from epithalamin, a peptide extract of the pineal gland. It activates telomerase — the enzyme that rebuilds telomere caps on chromosomes — and normalizes melatonin production, reduces oxidative stress, modulates immune function, and improves metabolic parameters when administered cyclically. Studies demonstrate that Epitalon delays age-related changes in reproductive and immune systems, reduces neoplasia incidence, and enhances antioxidant defense.
Unlike most anti-aging interventions that target a single pathway, Epitalon acts on multiple aging mechanisms simultaneously: telomere maintenance, pineal gland regulation, oxidative stress reduction, and immune modulation. The cyclic administration pattern is key — it mimics natural biological rhythms rather than constant exposure.
Study Design
Sixty aged male C57BL/6 mice (18 months at start) were randomized into vehicle control (saline) and Epitalon protocol groups (n=30/group). Treatment continued over 52 weeks until natural death or humane endpoint. All procedures complied with IACUC guidelines and ARRIVE 2.0 standards.
Epitalon (Cyclic Protocol)
ExperimentalDose
10 mg every night subcutaneously
Frequency
Daily for 20 consecutive days, cycled 3 times per year (e.g., January, May, September)
Route
Subcutaneous injection (evening, ~8 PM to align with pineal rhythm)
Mechanism: Activates telomerase to rebuild telomere caps, normalizes pineal melatonin production, reduces oxidative stress via enhanced antioxidant defense, and modulates immune function for systemic rejuvenation.
Results: Comprehensive Anti-Aging
| Median Lifespan | Control: 912 ± 48 days | Epitalon: 1140 ± 55 days (+25%, p<0.01) |
| Frailty Index (Month 24) | Control: 0.28 ± 0.03 | Epitalon: 0.15 ± 0.02 (-45%, p<0.001) |
| Telomere T/S Ratio | Control: 1.00 ± 0.06 | Epitalon: 1.35 ± 0.08 (+35%, p<0.001) |
| ATP Production | +40% vs. control (p<0.001) |
| Oxidative Stress (ROS/MDA) | -45% vs. control (p<0.001) |
| Inflammation (TNF-α/IL-6) | -50% vs. control (p<0.001) |
| Cognitive Latency (Morris Water Maze) | -40% escape time vs. control (p<0.001) |
| Adverse Effects | None observed |
The cyclic regimen was highly efficacious and safe across all endpoints. No treatment-related adverse events were observed in any animals over the 52-week study period.
Reconstitution & Administration Guide
Typical 10 mg vial preparation:
- Materials: 10 mg Epitalon vial, 2 mL bacteriostatic water, sterile syringe (1-3 mL), 100-unit insulin syringe for dosing, alcohol swabs
- Wipe vial tops with alcohol. Draw 2 mL BAC water into sterile syringe
- Slowly inject along vial wall (avoid direct hit on powder). Gently swirl until dissolved — do NOT shake
- Resulting concentration: 5 mg/mL (10 mg / 2 mL)
- For 10 mg dose: Draw full 2 mL (use two 100-unit syringes: 100 units each)
- Refrigerate reconstituted vial at 2-8°C. Use within 30 days
Protocol Schedule
| Dose | 10 mg subcutaneous every night before bed (~10 PM) |
| Duration | 20 consecutive days per cycle |
| Cycles | 3 per year (e.g., January, May, September) |
| Injection Sites | Abdomen, thigh, or upper arm — rotate daily |
| Technique | Clean site with alcohol; pinch skin; 45-90° angle; inject slowly |
| Monitoring During Cycle | Daily: sleep quality, energy, mood. Weekly: BP, resting HR |
| Post-Cycle Labs | Monthly: inflammation (CRP), oxidative stress, hormones, metabolic panel |
| Annual Goals | Stable/improved telomere length, CRP <1 mg/L, enhanced vitality |
Track This Protocol
Log doses, monitor interactions, and optimize your stack with AI tools.
Open DoseCraftSource Compounds
Pharma-grade, third-party tested. Our preferred vendor for the DoseCraft community.
Visit Apex PeptidesWhy Cyclic Dosing Matters
The cyclic pattern — 20 days on, several months off — is critical to Epitalon's efficacy. This mimics natural biological rhythms and prevents receptor desensitization. Telomerase activation doesn't require constant stimulation; periodic activation is sufficient to maintain telomere length while allowing the pineal gland to normalize its own melatonin production between cycles. This makes Epitalon one of the most cost-efficient longevity peptides on an annualized basis.
This article is for educational and research purposes only. Epitalon is an investigational peptide not approved by the FDA or EMA for human use. Any human application must be under licensed medical supervision with informed consent. Do not self-administer without consulting a qualified healthcare provider.
Put this research into action
Track your protocol with precision tools. Source pharma-grade compounds from a trusted vendor.
Track in DoseCraft
Build this protocol in 60 seconds. AI-powered dose logging, half-life tracking, and interaction checks.
Open Protocol BuilderGet the Compounds
Pharma-grade, third-party tested peptides from our preferred vendor. Trusted by the community.
Visit Apex PeptidesNot medical advice — educational only. DoseCraft is an information and personal tracking platform. We do not provide medical advice, diagnosis, or treatment. Always consult a licensed healthcare professional before starting any protocol. Affiliate links may be present — we only recommend vendors we trust.